Objective: Progressive graft arteriosclerosis is responsible for the majority of late deaths in cardiac transplant recipients. Despite many investigations, the pathogenesis of this disease remains undetermined and its control inadequate. A somatic gene transfer during the cold ischemic time and thus before transplantation might be a new therapeutic tool. This approach allows a long incubation time of the DNA and a safe transfer with liposomes and transferrin with less adverse effects for the organ recipient. Methods: The target cells (microvascular endothelial cells (MVECs)) for this gene transfer were isolated from rat hearts by perfusion with collagenase via an aortic cannulae. The cells were purified by changing the medium 30 min after subcultivation in order to remove fibroblasts and smooth muscle cells. The endothelial cells (ECs) were identified by typical morphology and the uptake of Dil-Ac-LDL. The gene transfer was carried out with a i-galactosidase reporter plasmid (pCMVi), cationic liposomes (Lipofectin ® ), and transferrin. Different transfection solutions were prepared with or without serum, and with different plasmid-liposome ratios and transferrin concentrations. The transfer rate was monitored with a semiquantitative orthonitrophenyl-i-D-galactoside (ONPG) assay and histologically by X-Gal staining. The cytotoxicity of this procedure was determined with a colorimetric ELISA with Alamar blue ® . The cardioplegic property of the transfection solution was tested in a Langendorff perfusion system monitoring the coronary blood flow over time after a cold ischemic time of 4 h. Results: The maximal gene expression could be detected after transfection with 4 vl Lipofectin, 2 vg pCMVi, and 16 vg transferrin/200 vl transfection solution. Under these conditions 60% of the cells showed a blue staining with X-Gal. Only 20% of the cells died during transfection. The lowest cytotoxicity during cold ischemic time for ECs was assessed with normal cell culture medium and the Buckberg solution. The best coronary flow rates after 4 h cold ischemia of the heart were measured for cardioplegia with St. Thomas and Buckberg solutions. In summary, the best transfection solution with a good cardioplegic property was the Buckberg solution. Conclusions: Finally, the results of this study show that an effective DNA delivery with a low toxicity into ECs is possible with a combination of liposomes and transferrin. This method might be useful for a safe and effective gene transfer into solid organs during the cold ischemic time and thus a therapeutic tool for chronic rejection.
Introduction
Gene transfer might be a useful strategy for the therapy of untreatable human diseases. Important requirements are a high transfection efficiency with a long expression time of the introduced genes with less adverse effects for the recipient. These goals have not been achieved yet. Transplant is widely applied and has revealed significant potential for gene therapy. Gene transfer might be feasible during the cold ischemic time at organ transportation. By adding genes to the organ perfusate the incubation time would allow for a high local gene concentration. Adverse effects for the recipient might be minimized by removal of the transfection solution prior to reperfusion. At the moment, few investigations describe a gene transfer via the vasculature during the cold ischemia of solid organs. In a heterotopic rat heart transplantation model an effective, but poorly quantified, gene transfer with liposomal vectors for a reporter plasmid was described [1] . In the rabbit an intracoronary gene transfer of interleukin-10 and transforming growth factor-i1 was carried out with replication defective adenoviral vectors. Gene product expression could be detected in the allograft and in the recipient serum [2] . A gene transfer technique for rat hearts with cationic liposomes and the hemagglutinating virus of Japan liposome (HVJ) during cold ischemia was described previously [3] . Both vectors only allowed for a low level of gene expression in endothelial cells (ECs). Inhibition of neointimal formation after cardiac transplantation by administration of antisense ODN against CDK2 kinase using this gene transfer technique was observed [4] . At this time, the benefit of viral vectors was not clearly proven, and adverse effects in the recipient could not be excluded [5] . Successful retrovirus-mediated gene transfer to vascular cells requires the induction of proliferating target cells. Thus these viruses are not applicable to transfect quiescent ECs. Immune response to adenoviral proteins is a major limitation to the use of these vectors [6] . However, adenovirus vectors in current use evoke non-specific inflammatory response leading to cell proliferation [5] .
Liposomes offer many advantages as gene transfer vectors: they can be used to transfer expression cassettes of unlimited size, they do not replicate or recombine to form an infectious agent, and they may evoke fewer inflammatory or immune responses. The only disadvantage at the moment is the lower efficiency compared with viral vectors. The present study was designed to optimize a liposome-mediated gene transfer into cultured microvascular endothelial cells (MVECs). These are the target cells for an in vivo gene transfer into solid organs during cold ischemia. Higher transfection rates might be achieved by varied liposome -plasmid ratios or concentrations, and changes in transfection solutions. The transfection solution has to guarantee for three properties: high transfection efficiency, low cytotoxicity, and a good organ conservation during cold ischemia. Therefore MVECs were isolated from rat hearts and transfected in vitro with a i-galactosidase reporter plasmid using a cationic liposome and transferrin. The i-galactosidase reporter plasmid was chosen in most investigations involving gene transfer into vascular cells. Transferrin is known to improve liposomal gene transfer into HeLa cells in vitro [7] . Different liposome and plasmid concentrations, and transfection solutions were tested. The transfection efficiency was monitored histologically and semiquantitatively with an ELISA. Cytotoxicity of the transfection procedure in cell culture was analyzed with an ELISA technique measuring the reduction of an indicator dye by cell proliferation and metabolism. The cardioplegic properties of the different transfection solutions were tested in a Langendorff perfusion system.
Materials and methods

Isolation of micro6ascular endothelial cells
Hearts from WKY rats (n =10) were explanted and perfused via an aortic cannulae with 10 ml calcium-free PBS, followed by perfusion with collagenase CLS II (Biochrome, USA; 1 mg/ml in 30 ml calcium-free PBS containing 1% BSA) for 30 min at 37°C. The perfusate was centrifugated and resuspended in M199 supplemented with ECGF (Boehringer, Germany), 10% fetal calf serum (FCS), and penicillin/streptomycin, seeded on 6-well plates and cultivated at 37°C in a 5% CO 2 incubator. The medium was changed the first time after 30 min to remove non-endothelial cells. The cells were subcultivated at the time of confluence followed by early medium exchange after 30 min. MVECs were identified by their typical morphology and uptake of Dil-Ac-LDL (Molecular Probes, USA). MVEC were seeded into Lab-Tek chamber slides and grown to confluence. Dil-Ac-LDL was added to a final concentration of 10 vg/ml and cells were cultivated for another 12-24 h at 37°C. After washing the cells three times with PBS they were fixated with 0.5% glutaraldehyde in PBS for 10 min at 4°C and thereafter examined with fluorescence microscopy at 571 nm (Zeiss Axiovert, Germany). The cell cultures were investigated for contaminating fibroblasts or smooth muscle cells by staining them with a monoclonal h-smooth muscle actin antibody (Sigma, USA), and the specific fibroblast antibody 'mAK AS02' (Dianova, Germany). For all gene transfer experiments MVECs isolated from one heart were used.
Gene transfer protocol
For transfection experiments the cells were grown to confluence in 96-well plates and Lab-Tek chamber slides (Costar). The transfection solution was prepared according to the following protocol: 8 vg of the igalactosidase reporter plasmid pCMVi (Qiagen, Germany) was diluted into 100 vl serum-free M199; 4-24 vl Lipofectin (Gibco, USA) was diluted into 100 vl serum-free M199 with or without 8-64 vg transferrin (Becton Dickinson, USA). Both solutions were mixed after 30 min at room temperature. After 15 min, 800 vl of M199 with or without 10% FCS, was added. For some experiments M199 (n= 4) was diluted with Buckberg cardioplegic solution 4:1 (Kö hler Chemie, Germany). A serial 1:1 dilution of the transfection agent was prepared. The cell layers were washed once with serum-free M199 and 200 vl of the transfection solu- tion was added per well. After an incubation time of 4 h at 37 and 4°C, the DNA-containing medium was replaced with 250 vl normal growth medium and incubated for a total of 48 h at 37°C.
To optimize the gene transfer, transfection solutions were prepared with different liposome -plasmid ratios (1:2, 1:1, 2:1, 3:1) and with or without 16 vg transferrin. The liposome-plasmid complexes (LPCs) were added to different transfection solutions: cell culture medium (M199) with or without FCS, and a bloodcardioplegic solution (Buckberg), which was diluted with M199 at a ratio of 1:4.
Analysis of transfection efficiency
For semiquantitative analysis of the transfection efficiency, an ELISA assay with orthonitrophenyl-i-Dgalactoside (ONPG) (Sigma, USA) in 96-well plates was carried out. ONPG is a chromogenic substrate for the i-galactosidase. The cleavage of ONPG results in a yellow color. The cell layers, were 48 h after transfection, fixed with 0.5% glutaraldehyde for 10 min at 4°C, washed twice with PBS, and incubated with 200 vl ONPG solution (8.8 mg/10 ml PBS with 0.1 M MgCl 2 ) at 37°C for 12 h. The optic density correlates with the total enzymatic activity representing the transfection rate. It was measured at 420 nm.
For microscopy the cell layers were stained with X-Gal (i-Gal Staining Kit, Invitrogen, USA). The gene product in transfected cells, the i-galactosidase, catalyzes the hydrolysis of X-Gal, producing a blue color that can be visualized under a microscope and the percentage of transfected cells could be calculated.
Analysis of cytotoxicity of transfection solutions in cell culture
The cytotoxicity of the LPCs to MVEC layers was monitored with the Alamar Blue Assay (BioSource, USA). This assay incorporates an oxidation-reduction indicator that changes color in response to chemical reduction of growth medium resulting from cell metabolism and proliferation. Reduction related to growth causes the indicator to change from oxidized (blue color) to reduced (red color) form. After removal of the transfection solution, normal cell culture medium supplemented with 10% Alamar blue was added to the 96-well plates. The change in color could be monitored with an ELISA reader at 620 nm at different time points. Cell proliferation correlates with the difference in change of the optic density measured after 0 and 12 h (DOD). Thus, a high cytotoxicity is associated with a low DOD. Different solutions, which might be useful as carriers for the DNA-liposome complexes and cardioplegia, were tested for cytotoxicity to MVEC cultures. Cells were grown to confluence in 96-well plates and after removal of cell culture medium, 250 vl of cold PBS, M199, M199 with 10%FCS, St. Thomas solution and Buckberg solution (Kö hler Chemie, Germany) were added. After 4 h at 4°C the cells were fed with normal cell growth medium supplemented with 10% Alamar blue. Cytotoxicity was monitored by changes in optic density over time as described above.
Analysis of cytotoxicity of transfection solutions during cardioplegia
Different transfection solutions and cardioplegic solutions were tested for cardiac conservation in a Langendorff perfusion system. Rat hearts were explanted and perfused with Krebs -Henseleit buffer for 30 min in a Langendorff system to stabilize. Cardiac arrest was induced by perfusion with 10 ml 4°C cold M199 ( + 8 mM KCl) with or without serum, St. Thomas or Buckberg solution for blood cardioplegia (M199 and FCS:Buckberg; 4:1). After 4 h of cold ischemia the hearts were reperfused with 37°C Krebs -Henseleit buffer. Coronary blood flow (ml/min) was monitored by collecting the perfusate for 1 min and compared with control hearts, which had no cold ischemia. A decline in coronary blood flow was marked for poor cardiac conservation during cold ischemic time.
All values are expressed as mean9 S.E. Comparisons between different groups were carried out using the Student's t-test.
Results
Micro6ascular endothelial cells
Pure MVEC cultures could be obtained by repeated subcultivation with early medium exchange after 30 min. MVEC formed a homogenous contact-inhibited monolayer with a typical cobblestone cell shape (Fig.  1A) . Specific endothelial staining with Dil-Ac-LDL could be demonstrated for more than 95% of the cells (Fig. 1B) . Only a few cells showed a positive staining for actin, demonstrating a contamination with fibroblasts or smooth muscle cells (Fig. 1C). 
Transfection efficiency
The transfection efficiency as monitored with a semiquantitative ELISA assay depends on the concentration of the LPC and the ratio of both substances. The best results were obtained for a 2:1 liposome-plasmid mixture (Figs. 2 and 3A) . The transfection could be enhanced twice with transferrin (Fig. 2) . Increasing the LPC concentration enhances the transfection rate (Fig.  3A) and the cytotoxicity leading to cell death as monitored with the Alamar blue assay (Fig. 3B) . The optimal transfection efficiency was found at the highest solution. The highest cytotoxicity was observed after incubation with St. Thomas solution (Fig. 5A). 
Cytotoxicity of transfection solutions during cardioplegia
After cold ischemia of 4 h, all hearts were beating at the end of the experiment (130 min). Within the first 30 min of reperfusion the coronary blood flow rapidly declined from 12 to 5-10 ml/min. The highest and most enduring flow rates were found after cardioplegia with St. Thomas or Buckberg solution (7 ml/min after 120 min). Normal cell culture medium was not useful for cardioplegia of the rat heart (3-5 ml/min flow after 120 min) (Fig. 5B). 
Gene transfer in 6itro with cardioplegic solutions
A gene transfer with liposomes at 4°C is possible, but it only succeeds in 60% of the better levels obtained at 37°C. Transferrin is able to enhance gene transfer at both temperatures. Comparable gene expression levels were measured for normal cell culture medium and the Buckberg cardioplegic solution (Fig. 6 ).
Discussion
Despite many investigations, ECs are difficult to transfect culturally. After transfection of human umbilical vein endothelial cells (HUVEC) with liposomes, 70% of the cells are viable with 0% of the cells transfected. Of the HUVECs, 50% could be transfected with a 19% viability by electroporation [8] . Adenoviral vectors allowed for a much higher transfer rate (90-100%) [9] . Compared with current studies our data demonstrate a higher transfer rate into ECs using a non-viral viral vector system (about 60%). This could be achieved by testing different concentrations of the plasmid, liposome and transferrin in different transfection solutions. To introduce a cytokine or hormone into a solid organ, possible transfection rate and the lowest possible cytotoxicity. At this concentration nearly 60% of the cells showed positive staining with X-Gal (Fig. 4). 
Cytotoxicity of transfection solutions in cell culture
After 4 h of cold incubation the lowest cytotoxicity and highest proliferation rate was observed for normal cell culture medium and for the Buckberg cardioplegic a transfection of 100% of the target cells does not seem to be necessary to achieve a detectable effect. In vivo transfection into uninjured ECs has its limitation in continuous blood flow and is therefore lacking in incubation. In vivo, adenoviral vectors are able to transfer the entire endothelium of sheep carotid arteries [10] . The transfection efficiency of adenoviral vectors and liposomes was compared in porcine coronary arteries. The gene levels obtained with the Ad5 vector was more than two orders of magnitude higher than obtained with Lipofectin. In a heterotopic heart transplantation model in the mouse, an effective gene transfer during cold ischemia could be achieved with liposomes. Gene expression could be detected in ECs, some arterial smooth muscle cells, and some myocytes, but it was not quantified [1] . In comparable models higher expression levels were obtained with adenoviral vectors and therapeutic effects were detectable [4] .
Our results for a liposome-mediated gene transfer demonstrate a much higher transfer rate in ECs. This could be obtained by optimizing the transfection efficiency with different liposome and plasmid concentrations and the use of transferrin. An optimal dosage was found by looking for the maximal transfer rate with an acceptable cytotoxicity. One disadvantage of the used preparation technique for the ECs was that the cell cultures contain ECs from epicardial coronary arteries and MVECs. The contamination rate with non-endothelial cells was very low.
The transfection solution for solid organ transplantation plays another important role. For clinical use a good cardiac conservation for 4 h at 4°C is mandatory. Normal transfection solutions (cell culture media like M199) are not useful for cardioplegia and in turn cardioplegic solutions (St. Thomas) are not useful for gene transfer. In contrast the Buckberg solution provides for both properties.
It remains to be proven whether transfection of solid organs is as feasible as it is in cell cultures with this gene transfer protocol. If comparable levels of gene expression can be found this might result in a powerful tool in transplant medicine. Patients might be less prone to chronic rejection or the rejection problem as a whole. Furthermore, with our method, the disadvantages of adenoviral expression systems would be excluded. One therapy for the treatment of chronic rejection might be the gene transfer of the constitutive nitric oxide synthase, using the antiproliferative effect of NO to vascular smooth muscle cells.
